4//SEC Filing
SYNTA PHARMACEUTICALS CORP 4
Accession 0001179110-14-004580
$MDGLCIK 0001157601operating
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 7:04 PM ET
Size
5.1 KB
Accession
0001179110-14-004580
Insider Transaction Report
Form 4
Vukovic Vojo
SVP, Chief Medical Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2014-03-03+141,211→ 141,211 totalExercise: $6.15Exp: 2024-03-03→ Common Stock (141,211 underlying)
Footnotes (1)
- [F1]The option vests as to 25% of the shares on March 3, 2015 and as to an additional 6.25% of the shares on the last day of each successive three-month period thereafter.
Documents
Issuer
SYNTA PHARMACEUTICALS CORP
CIK 0001157601
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001157601
Filing Metadata
- Form type
- 4
- Filed
- Mar 4, 7:00 PM ET
- Accepted
- Mar 5, 7:04 PM ET
- Size
- 5.1 KB